Ananya Health Analysis
What is Ananya Health?
Ananya Health builds CRCL, a portable cryoablation medical device for freezing abnormal cervical cells before they become malignant. The company says its platform works without consumable cryogen gas and targets standard-of-care treatment at one-tenth the cost of traditional cryo. It is preparing for FDA submission in 2026 and positions the device for use in clinics worldwide.
Location
400 29th St., Oakland, California 94609, US
Employees
1-10
Founded
2020
Revenue
$0-5M
Company Stage
Seed
YC Batch
S21
Product Features & Capabilities
- CRCL™ - portable cryoablation platform, easy-to-use, highly effective, battery-powered, closed loop system, delivers 5mm depth of freeze, reduces reliance on specialists, 1/10th the cost of traditional systems, no consumable cryogen.
Who are the founders of Ananya Health
Market Focus
Ananya Health primarily focuses on the healthcare industry, specifically in the field of cervical cancer prevention and treatment. They develop innovative medical tools, such as a portable cryoablation platform, aimed at treating pre-cancerous cells at the point of diagnosis in clinics worldwide.
Investors
- National Cancer Institute
- Dream Variation Ventures
- EHA Ventures
- Creative Destruction Lab
- eha Impact Ventures
Competitors Overview
Ananya Health operates in the cervical cancer prevention market, primarily focusing on a portable cryoablation platform designed to treat pre-cancerous lesions. Its main competitors include:
-
Teal Health: This company empowers women to perform their own cervical cancer screenings, offering a more personal and accessible approach to health management.
-
MobileODT: They provide a cervical cancer screening system that has received positive feedback, aiming to reduce the need for extensive screenings.
-
DySIS Medical: This company manufactures the DYSIS Advanced Cervical Imaging System, which standardizes colposcopy procedures to assist in detecting cancerous lesions.
-
Accession Therapeutics: They are developing a platform that targets various forms of cancer, potentially offering a broader range of treatments beyond cervical cancer.
-
Predica Diagnostics: This company focuses on improving cancer diagnosis and treatment, emphasizing meaningful medical procedures, which could appeal to patients concerned about unnecessary interventions.
-
Kovina Therapeutics: They are developing antiviral therapeutics specifically for cancers related to Human Papillomavirus (HPV), which is directly linked to cervical cancer.
-
Datexim: Specializes in AI-powered solutions for enhancing diagnostic accuracy in cervical cancer screening.
Notable differences include Ananya Health's emphasis on a portable treatment solution, while competitors like MobileODT and DySIS Medical focus more on diagnostic systems and imaging technologies.
Business Model
Investment capital, grants, tenders, contracts, and future product launches based on technology.
See something that needs updating? Suggest edits to this profile.